Sensitive and Selective Extractive Spectrophotometric Method for the Determination of Hydroxyzine Dihydrochloride in Pharmaceuticals
DOI:
https://doi.org/10.29356/jmcs.v54i4.918Keywords:
Spectrophotometry; hydroxyzine; orange II; pharmaceuticals.Abstract
Hydroxyzine dihydrochloride (HDH), a piperazine H1-receptor antagonist and antihistamine, is a rapid acting anxiolytic used principally as an anti-emetic. A sensitive, selective, and precise and accurate spectrophotometric method based on the formation of an ion-pair with orange II (ORG II) as ion-pair complexing agent was developed and validated for the determination of HDH in pharmaceuticals. The chloroform-extractable ion-pair complex exhibited an absorption maximum at 480 nm. Optimization of different experimental conditions is described. Beer’s law is obeyed in the range of 1.5-15 μg mL-1 with an apparent molar absorptivity value of 2.07 x 104 L mol-1 cm-1 and Sandell’s sensitivity value of 0.0216 μg cm-2. The limit of detection (LOD) and limit of quantification (LOQ) are 0.14 and 0.41 μg mL-1, respectively. A Job’s plot of absorbance versus molar ratio of HDH to ORG II indicated (1:2) stoichiometric ratio. Within- and between-day relative standard deviations at three different concentration levels were < 3%. The developed method was successfully applied to commercial tablets. The results obtained were in good agreement with those obtained using the official method.
No interference was encountered from co-formulated substances.
Recoveries were 96-109 %.
Downloads
References
2. Reynolds, J. E. F. Martindale. The Extra Pharmacopoeia, 30th ed.; The Pharmaceutical Press, London, 1993.
3. Capella-Peiro, M. E.; Bossi, A.; Esteve, R. J. Anal. Biochem. 2006, 352, 41-49.
4. Roberts, S. E.; Delaney, M. F. J. Chromatogr. A 1982, 242, 364-368.
5. Menon, G. N.; Norris, B. J. J. Pharm. Sci. 1981, 70, 697-698.
6. Papas, A. N.; Marchese, S. M.; Delaney, M. F. LC, Liq. Chromatogr. HPLC Mag. 1984, 2, 120–121.
7. Boberic-Borojevic, D.; Radulovic, D.; Ivanovic, D.; Ristic, P. J. Pharm. Biomed. Anal. 1999, 21, 15-22.
8. Pehoursq, F. J. Pharm. Tox. Meth. 2004, 50, 41-44.
9. Kintz, P.; Godelar, B.; Mangin, P. Forensic. Sci. Int, 1990, 48, 139-143.
10. Ackermann, H.; Kretzschmann, F.; Kruger, S.; Lexow, B. Nahrung-Food 1977, 21, 603-610.
11. Martinez-Algaba, C.; Bermudez-Saldana, J. M.; Villanueva-Camanas, R. M.; Sagrado, S.; Medina-Hernandez, M. J. J. Pharm. Biomed. Anal. 2006, 40, 312-321.
12. Beltagi, A. M.; Abdallah, O. M.; Ghoneim, M. M. Talanta 2008, 74, 851-859
13. Neng, Z.; Liang, Y.-Z.; Chen, B.-M.; Ping, W.; Xian, C.; Liu, F.-P. Chromatographia 2007, 66, 481-486.
14. Bouklouze, A.; Elbouzekraoui, M.; Cherrah, Y.; Hassar, M.; Kauffmann, J. M.; Electroanalysis 2002, 14, 1369-1374.
15. Ciaccio, L. L.; Missan, S. R.; McMullen, W. H.; Grenfeel, T. C. Anal. Chem, 1957, 29, 1670–1673.
16. Pasich, J.; Stasiewska, K. Acta. Pol. Pharm, 1962, 19, 181–182.
17. Basavaiah, K.; Charan, V. S. Acta Cienc. Indica Ser. Chem. 2001, 27, 91-96.
18. Basavaiah, K.; Charan, V.S. Il Farmaco 2002, 57, 9–17.
19. Basavaiah, K.; Charan, V.S.; Chandrashekar V. Ind. J. Pharm. Sci, 2002, 64, 251-253.
20. Sanrick, B.; Janik, B. Acta. Pol. Pharm, 1966, 23, 573–575.
21. Dembinski, B. Chem. Anal. (Warsaw), 1993, 38, 183–187.
22. Rajendraprasad, N.; Basavaiah, K.; Vinay, K. B. Chem. Ind. Chem. Eng. Quart, 2010, 16, 127-132.
23. The US Pharmacopeia (USP 28); The National Formulary (NF 23).; US Pharmacopeial Convention Inc, 2005, p.982.
24. Sane, R. T.; Vaidya, U. M.; Nayak, V. G.; Dhamankar, A. Y.; Joshi, S. K.; Doshi, V. J.; Sawant, S. V.; Malkar, V. B.; Pandit, V. R.; Sathe, A. Y.; Jukar, S.; Nadakarni A. D. Indian Drugs 1982, 19, 398–403.
25. Kurzawa, M.; Dembinski, B.; Szydlowska-Czerniak, A. Acta. Pol. Pharma. 1999, 56, 255-260.
26. Basavaiah, K.; Charan, V. S. Ind. J. Pharm Sci. 2003, 65, 660-662.
27. Sane, R. T.; Surve, V.; Francis, M. Indian Drugs 2000, 8, 390-393.
28. Gowda, B. G.; Melwanki, M. B.; Seetharamappa J. J. Pharm. Biomed. Anal. 2001, 25, 1021-1026.
29. Ramappa, P. G.; Revanasiddappa, H. D. Indian Drugs 2001, 38, 97-99.
30. Mostafa, S.; El-Sadek, M.; Alla, E. A. J. Pharm. Biomed. Anal. 2002, 28, 173-180.
31. Reddy, M. N.; Murthy, T. K.; Rao, Y. S.; Sushma, K.; Sankar, D . G. Indian Drugs 2002, 39, 106-109.
32. Skoog, D. A.; West, D. M. Principles of Instrumental Analysis, 2nd ed., Holt, Rinhart and Winston, New York, 1971, p. 104.
33. Zavis, H.; Ludvik, D.; Milan, K.; Ladislaw, S.; Frantisck, V. Handbook of Organic Reagents in Inorganic Analysis. John Wiley & Sons, New York, 1976, p. 364.
34. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical
Procedures: Text and Methodology Q2(R 1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.
35. Inczedy, J.; Lengyel, T.; Ure, A. M.; Gelencser, A.; Hulanicki, A. IUPAC Compendium of Analytical Nomenclature: Definitive Rules, Blackwell Science Inc., Boston, 1998.
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.